Page last updated: 2024-08-22

buthionine sulfoximine and bis(maltolato)oxovanadium(iv)

buthionine sulfoximine has been researched along with bis(maltolato)oxovanadium(iv) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cichon, AC; Clark, O; Di Florio, A; Jugov, R; Maeshima, R; Park, I; Rustin, S; Stoker, AW	1

Other Studies

1 other study(ies) available for buthionine sulfoximine and bis(maltolato)oxovanadium(iv)

Article	Year
Oxovanadium-based inhibitors can drive redox-sensitive cytotoxicity in neuroblastoma cells and synergise strongly with buthionine sulfoximine. Cancer letters, 2015, Feb-01, Volume: 357, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Cell Line, Tumor; Drug Synergism; Fibroblasts; Humans; Mice; Neuroblastoma; Oxidation-Reduction; Pyrones; Signal Transduction; Transfection; Vanadates	2015

Article

Year

Oxovanadium-based inhibitors can drive redox-sensitive cytotoxicity in neuroblastoma cells and synergise strongly with buthionine sulfoximine.

Cancer letters, 2015, Feb-01, Volume: 357, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Cell Line, Tumor; Drug Synergism; Fibroblasts; Humans; Mice; Neuroblastoma; Oxidation-Reduction; Pyrones; Signal Transduction; Transfection; Vanadates

2015